Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cathryn S Brock

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Clinical Medicine (London, England)|August 27, 2003
Emergencies in oncologyChristina Thirlwell, Cathryn S Brock
Expert Opinion on Emerging Drugs|November 3, 2005
Emerging targeted treatments for malignant gliomaPaul J Mulholland, Christina Thirlwell, Cathryn S Brock, et al.
Journal of Medicinal Chemistry|December 3, 2002
Antitumor imidazotetrazines. 40. Radiosyntheses of [4-11C-carbonyl]- and [3-N-11C-methyl]-8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (temozolomide) for positron emission tomography (PET) studiesGavin D Brown, Sajinder K Luthra, Cathryn S Brock, et al.
Journal of Cutaneous Pathology|November 16, 2007
Metastatic ductal eccrine adenocarcinoma masquerading as an invasive ductal carcinoma of the male breastSean R McLean, Sami Shousha, Nick Francis, et al.
EJNMMI Research|June 10, 2015
Preliminary clinical assessment of the relationship between tumor alphavbeta3 integrin and perfusion in patients studied with [(18)F]fluciclatide kinetics and [ (15)O]H 2O PETLaura M Kenny, Giampaolo Tomasi, Federico Turkheimer, et al.
Cancer Research|January 2, 2009
A new model for prediction of drug distribution in tumor and normal tissues: pharmacokinetics of temozolomide in glioma patientsLula Rosso, Cathryn S Brock, James M Gallo, et al.
Cancer Research|May 17, 2003
Metabolic activation of temozolomide measured in vivo using positron emission tomographyAzeem Saleem, Gavin D Brown, Frank Brady, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical Medicine (London, England)|August 27, 2003
Emergencies in oncologyChristina Thirlwell, Cathryn S Brock
Expert Opinion on Emerging Drugs|November 3, 2005
Emerging targeted treatments for malignant gliomaPaul J Mulholland, Christina Thirlwell, Cathryn S Brock, et al.
Journal of Medicinal Chemistry|December 3, 2002
Antitumor imidazotetrazines. 40. Radiosyntheses of [4-11C-carbonyl]- and [3-N-11C-methyl]-8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (temozolomide) for positron emission tomography (PET) studiesGavin D Brown, Sajinder K Luthra, Cathryn S Brock, et al.
Journal of Cutaneous Pathology|November 16, 2007
Metastatic ductal eccrine adenocarcinoma masquerading as an invasive ductal carcinoma of the male breastSean R McLean, Sami Shousha, Nick Francis, et al.
EJNMMI Research|June 10, 2015
Preliminary clinical assessment of the relationship between tumor alphavbeta3 integrin and perfusion in patients studied with [(18)F]fluciclatide kinetics and [ (15)O]H 2O PETLaura M Kenny, Giampaolo Tomasi, Federico Turkheimer, et al.
Cancer Research|January 2, 2009
A new model for prediction of drug distribution in tumor and normal tissues: pharmacokinetics of temozolomide in glioma patientsLula Rosso, Cathryn S Brock, James M Gallo, et al.
Cancer Research|May 17, 2003
Metabolic activation of temozolomide measured in vivo using positron emission tomographyAzeem Saleem, Gavin D Brown, Frank Brady, et al.
Pageof 1